CD4 and B-cell chronic lymphocytic leukemia: Despite the reduced CD4 cell count, the haematologic and clinical response to purine analogues increases macrophage cell activity and often also hypogammaglobulinemia; for this reason infections are more frequent at the beginning of the disease and decrease with improvement of CLL.